Diversified’s Teva Pharmaceuticals TEVA Stock Holding History

Diversified’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-310	Closed	-$3K	–	305
2020 Q4	$3K	Buy	+310	New	+$2.97K	﹤0.01%	339

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Diversified's TEVA Position: Q1 2021 in Review

Diversified sold out of Teva Pharmaceuticals (TEVA) in Q1 2021, closing a stake of 310 shares — an estimated $3K sold.

Diversified first reported a position in TEVA in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 451 funds tracked by Wall St. Rank hold TEVA as of Q1 2021.

Diversified reported no remaining Teva Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Diversified sold 310 Teva Pharmaceuticals shares in Q1 2021, an estimated $3K.
Diversified first reported a position in Teva Pharmaceuticals in Q4 2020 and held it in 1 quarter.
Diversified's Teva Pharmaceuticals position peaked at $3K in Q4 2020.
451 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2021.

Based on Diversified's 13F filing for Q1 2021, filed 5 May 2021.